Affymax, Inc.
Peptide drug maker completes Series C financing, adds new board member
Published in Healthcare Finance, Tax and Law Weekly, May 12th, 2004
The company also announced that Elizabeth A. Czerepak, a managing partner of BSHI, has joined Affymax's board of directors. Czerepak brings 18 years of experience in the pharmaceutical industry to Affymax. Existing investors, Apax Partners, MPM Capital and Sprout Group, also participated in the extension as well as an earlier close of this financing round. The company raised a total of $40 million from the Series C financing.
"As we prepare to enter the clinic with our first drug...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
More Articles from Healthcare Finance, Tax and Law Weekly
- Abbott Laboratories
AIDS researchers to Abbott: Norvir price increase cannot be tolerated - Abiomed, Inc.
Option grant to new CEO reported under NASDAQ marketplace rule - Advanced Magnetics, Inc.
Nanobiotech company reports loss of $0.07 per share - Agentase, LLC
Biocatalyst maker receives $100,000 investment - Aksys, Ltd.
Dialysis systems developer files registration statement with SEC - American Physicians Assurance Corp.
Insurers: Ohio market stabilizing but more work needed - More from this issue of Healthcare Finance, Tax and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
